Baseline Predictors of Long-Term Disability Progression in Ozanimod-Treated Participants With Relapsing Multiple Sclerosis

被引：0

作者：

Hartung, Hans-Peter ^{[1
,2
,3
,4
]}

DeLuca, John ^{[5
,6
,7
]}

Granziera, Cristina ^{[8
]}

Filippi, Massimo ^{[9
,10
,11
]}

Kappos, Ludwig

Cheng, Chun-Yen ^{[12
]}

Pachai, Chahin ^{[12
]}

Riolo, Jon ^{[12
]}

DeBoer, Erik ^{[12
]}

Silva, Diego ^{[12
]}

Penner, Iris-Katharina ^{[13
]}

机构：

[1] Heinrich Heine Univ, Dept Neurol, Fac Med, Dusseldorf, Germany

[2] Univ Sydney, Brain & Mind Ctr, Sydney, Australia

[3] Med Univ Vienna, Dept Neurol, Vienna, Austria

[4] Palacky Univ Olomouc, Olomouc, Czech Republic

[5] Kessler Fdn, West Orange, NJ USA

[6] Rutgers New Jersey Med Sch, Dept Phys Med, Newark, NY USA

[7] Rutgers New Jersey Med Sch, Dept Rehabil & Neurol, Newark, NJ USA

[8] Univ Hosp Basel, Basel, Switzerland

[9] IRCCS San Raffaele Sci Inst, Neuroimaging Res Unit, Div Neurosci, Neurol Unit,Neurorehabil Unit, Milan, Italy

[10] IRCCS San Raffaele Sci Inst, Neurophysiol Serv, Milan, Italy

[11] Univ Vita Salute San Raffaele, Milan, Italy

[12] Bristol Myers Squibb, Princeton, NJ USA

[13] Univ Bern, Dept Neurol, Inselspital, Univ Hosp Bern, Bern, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P307/309

引用

页码：354 / 355

页数：2